PLEASE NOTE: WE WILL BE ATTENDING FROM 15 TO 16TH NOVEMBER (TUE-WED)!!
LOOKING FOR DISTRIBUTORS IN: GERMANY, AUSTRIA, SWITZERLAND, THE NETHERLANDS, BELGIUM, SWEDEN, NORWAY, DENMARK, JAPAN, SOUTH KOREA, CHINA, CANADA ETC.
Sooma is developing non-invasive brain stimulation devices for treatment of neurological and psychiatric disorders. Our company offices are located in Helsinki Finland. Sooma is an ISO13485 and ISO9001 certified company.
Sooma manufactures the only tDCS device approved for routine clinical treatment of major depressive disorder (MDD), or 'major depression'. Our device has regulatory approvals in the e.g. EU (CE-mark), Australia, Malaysia with other countries and other clinical indications following soon.
The treatment by Sooma tDCS is non-invasive, painless and very well tolerated by the patients.
Sooma tDCS can be used as a standalone treatment for patients who do not tolerate antidepressant pharmaceuticals due to e.g. side-effects, or as an adjunct therapy to pharmaceutical treatment or cognitive therapy.
Sooma tDCS device is targeted for clinical routine use with unique design features, such as simplified user interface and solutions for reproducible dose delivery. The treatment can be carried out by a technician or a nurse and does not require supervision during the treatment.
Please visit our booth for product demonstration.
Sooma is now developing its international sales network and is looking for distributors. In case you are interested, please visit our booth.
Keywords: brain, depression, depressive disorder, stimulation, neurology, neurophysiology, neuromodulation.